Mr. Speaker, clearly the member opposite does not want to listen to me, but maybe he will listen to the CEO of Moderna who said Canada's early orders meant it was well positioned to receive early doses. This is the reality that the member opposite and his colleagues do not want to face. In fact, we were prepared and we have the best portfolio: seven promising candidates, four of them under regulatory review.
When the vaccines are safe we will be delivering them to Canadians.